Imbed Biosciences named Terry Bromley its new Chief Executive Officer, the company announced recently.

According to a release, Bromley has more than 30 years of experience in the medical device, regenerative medicine, and wound and skin markets. He will be tasked with fostering the company’s growth and continuing the biotech company’s mission to transform the future of soft tissue repair through advanced technologies focused on improving patient outcomes.

“Terry brings a wealth of commercial leadership experience in the wound and skin care sector, delivering innovation and building high-performing teams,” Imbed Biosciences Founder and Chief Scientific Officer Ankit Agarwal said in a statement. “I’m excited to welcome Terry to the Imbed Biosciences family.”

Agarwal previously held the title of CEO.

Bromley served as Senior Vice President, Commercial Operations and Global Sales at Avita Medical prior to Imbed Biosciences.